Clinical Trials Sponsored by INRESA Pharma

Total 8376 results

INRESA Pharma
RCTs

Completed

The Sorbact® Antimicrobial Dressing in the Holistic Wound Management Of Diabetic Foot ulCers (Phase III Study) (ADHOC)

Foot Ulcer, Diabetic

France, Czechia, Poland
University Hospital, Strasbourg, France
INRESA Pharma

Completed

Sorbact TM: Effect of a Microbial Binding Dressing on Wound Healing After Pilonidal Sinus Excision (SORKYSA)

Sinus Pilonidal

France
Inreda Diabetic B.V.

Withdrawn

A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System (STABLE-1)

Diabetes Mellitus, Type 1

Netherlands
Inreda Diabetic B.V.

Completed

Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes (FAST 1)

Type 1 Diabetes

Netherlands
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
St. Teresa Medical

Completed

A Study to Assess the Safety and Performance of SurgiClot® in the Treatment of Cancellous Bone Bleeding

Cancellous Bone Bleeding

Norway, United Kingdom
Hospital Madre Teresa

Completed

Postoperatory Analgesia After Total Knee Arthroplasty (PAINCONTROL)

PAIN

Brazil
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE (MAGNOLIA)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, Spain, Korea, Republic of, Italy, Hungary, France, Netherlands, Canada, Latvia, Germany, United Kingdom, Norway, Sweden, Ireland, Czechia, Switzerland
María Teresa Moreno Asencio

Recruiting

Analysis of the Incidence of Cholangiocarcinoma on Choledochal Cyst in a Western Center (QuiCo)

Incidence of Cholangiocarcinoma on Choledochal Cysts | Postoperative Complications in Choledochal Cysts | Choledochal Cyst Monitoring

Spain
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE (ASTER)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, Spain, Japan, Canada, Ireland, Italy, Korea, Republic of, France, Switzerland, Hungary, Netherlands, Latvia, Germany, Norway, Sweden, Czechia, United Kingdom
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
Inesa Astramskaitė

Completed

The Influence of Sedation and General Anesthesia to Patients' Psycho-emotional State Undergoing Wisdom Teeth Extraction

Anxiety | Fear | Teeth, Impacted | Tooth-loss

Lithuania
Inesa Astramskaitė

Completed

Validation of Universal Scale in Oral Surgery (USOS) for Patient's Psycho-emotional Status Rating

Fear, Dental
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Teresa Meier

Recruiting

Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer

Endometrial Cancer

United States
Thorne Research Inc.
Indena S.p.A

Terminated

Effects of Quercetin on Metabolic Health

Aging | Lipid Metabolism | Quercetin

United States
Queen's University, Belfast
Invest NI

Completed

Project Daire: Derry/Londonderry as the Nexus City for Food, Education, Trust and Health (Daire)

Knowledge, Attitudes, Practice

United Kingdom
Indena S.p.A
Sintesi Research Srl

Withdrawn

Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain (IDN5243inLBP)

Low Back Pain

Italy
IRCCS San Raffaele
Indena S.p.A

Unknown

Safety of Ginkgo Biloba Leaf Extract (GiBiEx)

Healthy

Italy
Althaia Xarxa Assistencial Universitària de Manresa

Completed

Infiltrations With Collagen in Episiotomy and Cesarean Scars

Pelvic Pain

Spain
Althaia Xarxa Assistencial Universitària de Manresa

Unknown

To Survive After ICU Discharge

In-Hospital Mortality | Number of ICU Readmission | Number of Warnings On-duty

Spain
Althaia Xarxa Assistencial Universitària de Manresa

Completed

Effect of Asynchronies on Sleep Disruption During Mechanical Ventilation (SleepUCI)

Sleep

Spain
Althaia Xarxa Assistencial Universitària de Manresa

Completed

Efficacy of Sound Insulation and Music Therapy on the Comfort of Mechanically Ventilated Patients Admitted to Intensive Care Unit

Intensive Care Units

Spain
Althaia Xarxa Assistencial Universitària de Manresa

Completed

Rest After Spontaneous Breathing Trial for Prevention of Post-extubation Failure

Weaning Failure

Spain
PT Sydna Farma
PT Pharma Metric Labs

Completed

Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers

Drug Use

Indonesia
UMC Utrecht
Inreda Diabetic B.V.; Dutch National Health Care Institute

Not yet recruiting

Dual Hormone Closed Loop in Type 1 Diabetes (DARE)

Diabetes | Diabetes Mellitus, Type 1 | Diabetes type1

Netherlands
Monash University
Caring Pharmacy; Bionime Corporation; Tigas Pharma

Active, not recruiting

Prevention and Treatment of Diabetes in Adults

PreDiabetes

Malaysia
Althaia Xarxa Assistencial Universitària de Manresa

Not yet recruiting

Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions

Pregnancy | Hemodynamic Instability | Epidural | Fetal Cardiac Disorder

Spain
Althaia Xarxa Assistencial Universitària de Manresa

Recruiting

Lung Volume Preservation During Extubation

Weaning Failure | Pulmonary Collapse

Spain
Althaia Xarxa Assistencial Universitària de Manresa

Completed

Efficacy of Stimulation of the Efferent Loop and Rehabilitation of the Pelvic Floor in the Quality of Life of Patients Who Underwent Anterior Resection of the Rectum (ENESP): Randomized Clinical Trial (ENESP)

Rectal Cancer

Spain
M.D. Anderson Cancer Center
Indena S.p.A

Active, not recruiting

The Effects of Ginseng on Cancer-Related Fatigue

Solid Tumors | Advanced Cancers

United States
Althaia Xarxa Assistencial Universitària de Manresa

Terminated

High Flow Nasal Cannula in Severe Sepsis (OPTISEPSIS)

Severe Sepsis

Spain
Istituto Oncologico Veneto IRCCS
Indena S.p.A

Completed

Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients (ROSAM)

Oral Mucositis | Head-and-neck Squamous Cell Carcinoma

Italy
Althaia Xarxa Assistencial Universitària de Manresa

Terminated

Cerebral Autoregulation in Non Neurological Critical Patients.

Systemic Inflammatory Response Syndrome | Critical Illness | Complication of Ventilation Therapy | Failed Moderate Sedation During Procedure, Sequela

Spain
Althaia Xarxa Assistencial Universitària de Manresa

Terminated

Extubation Failure Prevention in High Risk Patients by High-flow Conditioned Oxygen Therapy vs. Standard Oxygen Therapy

Respiratory Failure

Spain
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
UCB Pharma SA

Completed

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Epilepsy

United States, Belgium, Czechia, France, Germany, Hungary, Ireland, Italy, Mexico, Poland, Spain, United Kingdom
UCB Pharma SA

Completed

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Epilepsy, Partial

Canada, United States
Vifor Pharma, Inc.

Terminated

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD)

Hyperkalemia

United States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
UCB Pharma SA

Completed

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy

Belgium, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
UCB Pharma SA

Completed

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

Generalized Epilepsy
UCB Pharma SA

Completed

Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

Dermatitis, Atopic
UCB Pharma SA

Completed

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] (PRECiSE 3)

Crohn's Disease

United States, Australia, Austria, Belarus, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, Israel, Italy, New Zealand, Norway, Poland, Russian Federation, Serbia, Singapore, Slovenia, South Africa, Spain, Ukraine, Canada and more
NicOx
Theradis pharma; Iris Pharma

Withdrawn

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) (Goldeneye)

Adenoviral Conjunctivitis

Spain
UCB Pharma GmbH

Completed

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy (VICTOS)

Focal Epilepsy With and Without Secondary Generalization

Germany, Austria
UCB Pharma SA

Completed

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

Unverricht-Lundborg Disease

France, Italy, Sweden, Finland, Netherlands, Tunisia, Réunion
UCB Pharma SA

Completed

Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects

Healthy Volunteers

United Kingdom
UCB Pharma SA

Terminated

Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease (REFRESH-PD)

Advanced Idiopathic Parkinson's Disease

United Kingdom

Clinical Trials Sponsored by INRESA Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations